News & Perspective

Oct 18, 2005

Oct 18, 2005

Roche to build Tamiflu plant in US

(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it would build a plant in the United States to make oseltamivir (Tamiflu) and also consider licensing other companies to make the drug in the face of a possible flu pandemic.

Oct 17, 2006

Oct 17, 2006

Baxter says cell-based H5N1 vaccine shows potential in trial

(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.

Jun 20, 2007

Jun 20, 2007

Japanese to study behavioral effects of Tamiflu

(CIDRAP News) – The company that markets oseltamivir (Tamiflu) in Japan has announced it will launch new studies to explore whether the antiviral drug contributes to adverse psychiatric and neurologic events in teenagers.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»